Granahan Investment Management - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 107 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q3 2016$2,518,000
-14.8%
657,496
-4.3%
0.08%
-24.1%
Q2 2016$2,954,000
+12.3%
686,921
+20.9%
0.11%
+12.5%
Q1 2016$2,630,000
-54.2%
568,001
-0.9%
0.10%
-51.5%
Q4 2015$5,748,000
-9.4%
573,101
-32.6%
0.20%
+1.0%
Q3 2015$6,345,000
-81.0%
850,601
+20.5%
0.20%
-79.3%
Q2 2015$33,474,000
+26.8%
705,601
-2.1%
0.95%
+25.4%
Q1 2015$26,409,000
+7.5%
720,781
+16.5%
0.76%
+5.4%
Q4 2014$24,575,000
+299.5%
618,860
+100.7%
0.72%
+277.4%
Q3 2014$6,152,000308,3600.19%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,120,000$8,355,0003.30%
HARVEY CAPITAL MANAGEMENT INC 301,100$2,246,0000.90%
BB BIOTECH AG 1,482,114$11,057,0000.35%
Rhenman & Partners Asset Management AB 225,000$1,679,0000.27%
SECTORAL ASSET MANAGEMENT INC 692,036$5,163,0000.24%
Granahan Investment Management 850,601$6,345,0000.20%
NumerixS Investment Technologies Inc 133,863$999,0000.11%
C WorldWide Group Holding A/S 625,510$4,666,0000.08%
Eventide Asset Management 174,000$1,298,0000.08%
Gruss Capital Management LP 300,000$2,238,0000.07%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders